FOR ANIMALS FOR HEALTH FOR YOU

Similar documents
DELIVERING SHARED VALUE

Vice President of Development Denver, CO

Speaking notes submitted by Dr. Duane Landals. on behalf of the Canadian Veterinary Medical Association (CVMA)

Aerial view of the Faculty of Veterinary Medicine Utrecht

TOGETHER WE ACHIEVE THE BEST IN ANIMAL WELLBEING

Combating Antimicrobial Resistance: A Manufacturing Perspective

Implications for Registration and Approval of Innovative Technologies

Strategy 2020 Final Report March 2017

MAKING AN IMPACT CORPORATE SOCIAL RESPONSIBILITY SUMMARY 2017

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

One Health, One Purpose:

TABLE OF CONTENTS. 4. VIP PETCARE COLORS a. Core Colors b. Accent Colors. 5. VIP PETCARE FONTS a. Font Guidelines

Building a Global Leader and Creating Value

Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016

international news RECOMMENDATIONS

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

RESPONSIBLE ANTIMICROBIAL USE

Position Description PD895 v3.1

Antimicrobial resistance (AMR): action plans implementation. Kamil Saytkulov February, Moscow

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

Action Plan Goal 2 Surveillance and Monitoring Strategies:

Overview of the OIE PVS Pathway

The Challenges of Globalisation for Veterinary Education. Dr. David M. Sherman

OIE Strategy on Antimicrobial Resistance and the need for new diagnostic tools

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

Contact Person: Dr Samuel Kahariri; Dr Samuel Makumi;

For personal use only

Canada s Activities in Combatting Antimicrobial Resistance. Presentation to the JPIAMR Management Board March 29, 2017

Responsible Antimicrobial Use

Government Initiatives to Combat Antimicrobial Resistance (AMR)

Nestlé PURINA PetCare. BUSINESS REVIEW North America SEPTEMBER Nestlé Purina PetCare

Cats Protection our strategy and plans

Housing on the Fountainbridge site

Animal Health and Welfare Best Practices. Claresholm Veterinary Services Ltd Dr. Ken Wright, DVM, BSc

a commitment to milk quality

Pan-Canadian Framework and Approach to Antimicrobial Resistance. Presentation to the TATFAR Policy Dialogue September 27, 2017

National Action Plan development support tools

Draft ESVAC Vision and Strategy

Inaugural Annual Letter 2019

BEST PRACTICE POLICY ON ANTIBIOTICS STEWARDSHIP

WHO (HQ/MZCP) Intercountry EXPERT WORKSHOP ON DOG AND WILDLIFE RABIES CONTROL IN JORDAN AND THE MIDDLE EAST. 23/25 June, 2008, Amman, Jordan

funded by Reducing antibiotics in pig farming

OIE AMR Strategy, One Health concept and Tripartite activities

of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014

OIE strategy on AMR and the Prudent Use of Antimicrobials

Advancing Veterinary Medical Education

MIDDLE EAST REGIONAL ANIMAL WELFARE STRATEGY

Lessons learned from implementing EVM on a large scale IT portfolio at the Department of State

The Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach

INTRODUCTION TO ANIMAL AND VETERINARY SCIENCE CURRICULUM. Unit 1: Animals in Society/Global Perspective

Physician Veterinarian Do you have the Bayer Spirit?

Alcona Humane Society Strategic Plan

o VETERINARY IMMUNODIAGNOSTICS MARKET- GLOBAL OPPORTUNITY ANALYSIS AND INDUSTRY FORECASTS TO 2022 Report ID: MRAM Publishing Date: July, 2017

My Goals and Accomplishments in the Veterinary Science Project

Breeder Cobb 700. The Cobb 700 has been introduced to meet the. Ten years of research to develop Cobb 700. Breeder Performance

328 A Russell Senate Office Building United States Senate

Member Needs Assessment Report to the Members June 2012

OBJECTIVE: PROFILE OF THE APPLICANT:

American Veterinary Medical Association

Jaipur Declaration on Antimicrobial Resistance

ruma Cattle Responsible use of antimicrobials in Cattle production GUIDELINES

CONTINUING EDUCATION AND INCORPORATION OF THE ONE HEALTH CONCEPT

CNIB s Guide Dog Program. Mobility. Independence. Partnership.

EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA

The European AMR Challenge - strategic views from the human perspective -

The role of veterinarians in animal welfare and intersectoral collaboration

Animal Welfare Update This document provides an overview of Costco s global status on animal welfare.

The promise of aquaculture and the challenge of antimicrobial use

Wageningen Bioveterinary Research. Biomedical and veterinary research to safeguard animal and public health

Private Sector Solutions for Public Health Challenges Promoting handwashing practices across Asia

Sustainability : an opportunity for poultry production. Christine AGNES Elanco Food Chain Leader EMEA

Dr René A. Carlson President, World Veterinary Association. The Current and Future Role of the WVA in Continuing Education for Veterinarians

COPING WITH ANTIMICROBIAL RESISTANCE

Michigan Pet Fund Alliance's Getting to the Goal Conference

Dr Nick Hill. Contents. Our mission is to develop products which educate and empower owners to provide a higher level of care for their pets.

Effective Vaccine Management Initiative

Strategizing to manage emerging animal diseases in South Africa. Dr Pieter Vervoort, National Animal Health Forum chairperson

OIE Standards on Animal Welfare, and Capacity Building Tools and Activities to Support their Implementation

Pfizer Position on Antimicrobial Resistance Management. Kirill Tverskoy, Medical Director Pfizer Russia February 21, 2017

Initiatives for Addressing Antimicrobial Resistance in the Environment. Executive Summary

The Future of Antibiotic Alternatives

Questions and Answers on the Community Animal Health Policy

Action and Experience of Containment of AMR in Veterinary Sector JAPAN

Veterinary Medicine Master s Degree Day-One Skills

Youth Pork Quality Assurance Plus

PRODUCT INNOVATION AND CORPORATE GROWTH

OPEN MEDICINE INSTITUTE & HOWARD YOUNG FOUNDATION S Tick-Borne Illness Center of Excellence

ALDI US. Animal Welfare. Buying Policy Date: 05/

RESPONSIBLE 39.36% 82% 91% CHAIRMAN S MESSAGE USE OF ANTIBIOTICS BANNED

The Internet of Things: The possibilities are endless, but how will we get there? Charles Reed Anderson

Science Based Standards In A Changing World Canberra, Australia November 12 14, 2014

A world without antibiotics? I cannot imagine. Page 1

3. records of distribution for proteins and feeds are being kept to facilitate tracing throughout the animal feed and animal production chain.

OIE Collaborating Centres Reports Activities

Global Overview on Antibiotic Use Policies in Veterinary Medicine

Dealing with dairy cow lameness applying knowledge on farm

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

Internship/Seasonal Employment Opportunities 2018

Recruitment Pack Cattery Team Leader (Part-time) Battersea Dogs & Cats Home

Comments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014

Transcription:

FOR ANIMALS FOR HEALTH FOR YOU

WORLD LEADER IN ANIMAL HEALTH

At Zoetis, we discover, develop, manufacture and market veterinary medicines, vaccines and diagnostics, complemented by genetic tests, biodevices and a range of services. We work to help meet the growing worldwide demand for meat, poultry, fish, eggs and dairy foods and to care for the increasing number of pets. With our singular focus on animal health, we strive to make our products, services and people the most valued by veterinarians and livestock farmers around the world. 1

WE SUCCEED WHEN OUR CUSTOMERS SUCCEED 2

SUPPORTING AN INDUSTRY THAT TOUCHES EVERYONE The animal health industry serves two segments: livestock such as beef and dairy cattle, pigs, poultry, fish and sheep and companion animals including dogs, cats and horses. Powerful and durable trends are driving demand for animal health products and services in both segments and fueling the industry s 5 to 6 percent compound annual rate of growth. These include human population growth, a rising middle class in emerging markets, and a steady migration of people from rural communities to urban centers. Nevertheless, our customers are challenged by limited natural resources, the threat from transboundary and emerging infectious diseases, and other constraints. This creates opportunities for innovations that lead to new animal health solutions. To help our customers address these challenges in ways that are truly relevant for their businesses and animals, we put three interconnected capabilities to work for our customers: Our ability to work shoulder to shoulder with veterinarians and livestock farmers, thanks to the most well-trained sales, veterinary and technical professionals in the industry. The development of clinical innovations rooted in veterinary medical needs, evidence-based research, and an understanding of market opportunities, which comes from continuously listening to our customers. A global supply chain team that provides our high-quality products at a competitive price when and where our customers need them. BUILDING A CULTURE OF LISTENING AND PROBLEM SOLVING We make the most of our local presence and relationships to address our customers most pressing health challenges. When the animals in their care thrive, we all benefit. Our model is clear: our customers are the experts in their businesses, and we provide products and services that help them protect their animals health and improve their profitability. We best serve our customers when we have honest, face-to-face conversations about their needs and the solutions we can deliver to help meet them. Playing such an important role requires the best use of our science and technology as well as our day-to-day, hands-on support. By developing new products and enhancing our current portfolio, we address current needs and anticipate future ones. Veterinarians and livestock farmers around the world know they can count on us to solve their problems, so they can care for their animals and run their businesses productively. DELIVERING SOLUTIONS TO PREDICT, PREVENT, DETECT AND TREAT DISEASE Our customers be they veterinarians or livestock farmers demand solutions across the continuum of animal care to predict, prevent, detect and treat illness, as well as solutions to help improve livestock animal productivity. Our products and services for cattle, pigs, poultry, sheep and fish help conditions that can adversely impact their health and performance, while also ensuring the sustainable production of quality meat, poultry, fish, eggs and dairy foods. Our products and services for cats, dogs and horses help them live longer, healthier lives and address conditions such as arthritis pain and inflammation, skin allergy, parasitic disease and bacterial infection. At the center of our portfolio are medicines to treat disease, vaccines to help prevent it and diagnostic tests to evaluate health rapidly and accurately. We are expanding complementary solutions such as genetic tests to help predict wellness and performance traits in cattle and sheep to help inform selection of replacement animals for herds and flocks. Our portfolio of biodevices sets the standard for in ovo vaccination technology and the efficiency of related operations in poultry hatcheries worldwide, as well as for rapid, consistent vaccination of farmed fish against disease threats. Our sensor technologies paired with data analytics are becoming ever more important tools to help veterinarians and farmers predict and detect disease and ultimately make better healthcare decisions. 3

THE ZOETIS DIFFERENCE OUR CHARACTERISTICS THREE INTERCONNECTED CAPABILITIES DIVERSE PRODUCT PORTFOLIO We have a diverse and durable portfolio of approximately 300 product lines comprised of medicines, vaccines and diagnostic products complemented by biodevices, genetic tests and a range of technical services. DIRECT CUSTOMER RELATIONSHIPS We achieve all that we can by building strong relationships through direct interaction with our customers in approximately 45 countries. Our sales and technical service professionals seek to delight our customers, listening to their needs and concerns and helping them succeed. GLOBAL LEADERSHIP AND SCALE We market our products in more than 100 countries, giving veterinary professionals, livestock farmers and pet owners access to our product portfolio and technical expertise on a global scale. SINGULAR FOCUS Our people have a singular focus on animal health. We are passionate about our customers and the health of the animals in their care. We take ownership of delivering results that matter to our customers. INNOVATION We are committed to researching and developing ever-better solutions to address our customers most pressing animal health challenges and deliver real value to their businesses. HIGH-QUALITY MANUFACTURING AND SUPPLY We know our customers depend on a reliable supply of high-quality products at competitive prices. We have built an efficient global manufacturing and supply network of internal sites and external partners to meet our customers expectations. 4

GUIDED BY OUR CORE BELIEFS Our people drive our success. We have instilled a highly collaborative culture guided by our Core Beliefs where colleagues have a sense of ownership and derive satisfaction from seeing and measuring the impact of their achievements on the success of our company, our customers and their businesses. Our colleagues distinguish Zoetis from our competition. We grow our company when we create an environment where colleagues excel. Integrity is the guiding principle for all our decisions and relationships. We are honest and trustworthy in our words and actions. We are passionate about our customers and the health of animals in their care. Our customers come first, and when they succeed, we succeed. We take ownership of delivering results that matter. We constantly pursue faster, simpler and better ways of doing business. Zoetis is much more than the sum of its parts. We work together with a common purpose, sharing knowledge and resources for the best interest of our company as a whole. KEY FACTS 45 APPROXIMATE NUMBER OF COUNTRIES WHERE WE HAVE A DIRECT PRESENCE 100+ COUNTRIES IN WHICH WE MARKET OUR PRODUCTS 300 APPROXIMATE NUMBER OF PRODUCT LINES 65+ YEARS OF EXPERIENCE IN ANIMAL HEALTH WE PROVIDE: MEDICINES VACCINES DIAGNOSTICS GENETIC TESTS BIODEVICES SERVICES 5

DIRECT CUSTOMER RELATIONSHIPS We use our global scale and local presence to our customers advantage by working alongside them, listening to their most pressing challenges and developing integrated solutions to address their needs. STANDING SIDE BY SIDE We work with veterinarians and producers to address both chronic and emerging diseases that can impact their herds and flocks. We help veterinarians introduce pet wellness programs and run their practices more efficiently. We strive to understand what matters most to our customers and how to help them grow their businesses successfully. In addition to having a presence around the world, our sales representatives and technical services professionals speak the same language as our customers and share the same experiences. Many of our people working in the livestock side of Zoetis grew up in agriculture and on farms. On the companion animal side, many grew up working in veterinary practices and are caring pet owners themselves. Our technical services team is made up of veterinary professionals and nutritionists who are skilled educators and have expertise in the prediction, prevention, detection and treatment of disease. We have a deep knowledge of the marketplace, the opportunities, the challenges, and the products being used. We focus on bringing our customers integrated solutions. These solutions come not only from our diverse product portfolio, but also from the expertise and experience of our people, who are passionate about bringing together comprehensive offerings that solve our customers most pressing challenges. We work to make the experience of doing business with Zoetis exceptional, by continuously connecting with customers in ways that are important to them. We empower our people to perform at their best through learning and development opportunities; offering outstanding products that meet our customers critical needs; and delivering them with high quality at the right time. We strive to make it easier for customers to do business with us, when, where and how it s convenient for them. DIRECT ENGAGEMENT WITH PET OWNERS At Zoetis, we understand the importance of the human-animal bond and how pets are increasingly seen as members of the family. In several markets around the world, we are connecting directly with pet owners by supporting their needs for healthcare information through online resources and social media communities. 6

7

INNOVATION We focus our innovation on discovering and developing integrated solutions that our veterinarian and livestock producer customers need to succeed. We create new insights to better predict, prevent, detect and treat disease and to maximize healthy performance and production. Our Research and Development delivers new platforms of knowledge that can become the basis for continuous innovation. Internal discoveries, coupled with external research collaborations, result in the delivery of novel vaccine, pharmaceutical or biopharmaceutical products, diagnostics, biodevices, and genetic tests, as well as sensor technologies combined with data analytics, which help our customers overcome their toughest challenges. We also seek to integrate products for maximum benefit to our customers, such as using diagnostic tests in combination with vaccination and treatment protocols to manage specific disease conditions, or combining our automation solutions for vaccination with safe and effective Zoetis vaccines. Our comprehensive R&D efforts are comprised of more than 300 programs and reflect our commitment to advancing animal health with better solutions. Our rigorous approach to project selection and prioritization helps us develop these solutions with speed, flexibility and efficiency. Our commitment to continuous innovation means we actively work to broaden the reach of our existing products and enhance the value they bring to customers by developing more convenient formulations and combinations; obtaining new claims that expand product benefits; adapting for use in additional species; and by expanding approval into more countries. Our R&D network, with global headquarters in Kalamazoo, Michigan, includes teams in the United States, Latin America, Europe and Asia. Our regional footprint, supported by our in-country and global market research, allows us to listen to livestock producers and veterinarians, region by region, and translate their challenges into practical and cost-effective products tailored to meet their needs. Our global presence is at the core of our ability to respond rapidly and accurately when emerging infectious diseases spread and threaten the lives of people, animals and livelihoods. Our internal innovation is strengthened by approximately 100 research alliances. We join forces with partners throughout the animal health, pharmaceutical, biotechnology and agribusiness industries, as well as leaders in academia and public and private institutions. We strive to be the animal health partner of choice. INNOVATION ACROSS THE CONTINUUM OF VETERINARY CARE Our broad R&D capabilities place Zoetis in a unique position to serve the needs of veterinarians across the continuum of animal healthcare as they strive to predict, prevent, detect and treat disease. PREDICT PREVENT DETECT TREAT GENETICS VACCINES, BIODEVICES & AUTOMATION DATA ANALYTICS & SENSORS DIAGNOSTICS MEDICINES 8

9

HIGH-QUALITY MANUFACTURING AND SUPPLY Our manufacturing and supply network including more than two dozen manufacturing facilities around the world provides expertise in production for biologicals, pharmaceuticals, medicated feed additives, biodevices and diagnostics. Our manufacturing and supply colleagues work closely with R&D teams to make sure we transition technology from the lab to full-scale production easily and efficiently. The result: high-quality, reliable supply at competitive costs. AN UNWAVERING COMMITMENT TO QUALITY In addition to our owned manufacturing sites, we work with third-party manufacturers worldwide that meet our high standards. By balancing internal and external resources, we maximize our investment in biologics and high-value formulations; provide access to niche products and technologies; benefit from the efficiencies of other large-scale producers; increase speed to market; and optimize our network for future growth and efficiency. With our experience in managing the complexity of animal health product supply including a long-standing culture of continuous improvement we not only provide consistent product quality, but we also manage change effectively, partner on innovation for rapid development and supply, and integrate promising acquisitions seamlessly. With this integrated supply network, we have the flexibility to put our innovative products in the hands of our customers quickly, efficiently and at a competitive price. In fact, many of our R&D operations are co-located with manufacturing sites, so our development and manufacturing teams can work side by side and embed production design directly into the R&D process. Veterinarians and livestock farmers benefit from this close collaboration because it helps move projects to commercial-scale production more efficiently and helps bring new and enhanced products to market faster. We work closely with government agencies and other key regulators in the countries where we operate to ensure that we follow their guidelines and regulations and maintain high quality standards. 10

11

DIVERSE PORTFOLIO Zoetis offers a diverse portfolio comprised of approximately 300 product lines that serve eight core species: beef and dairy cattle, pigs, poultry, sheep, fish, dogs, cats and horses. Our portfolio includes six product categories: anti-infectives, vaccines, parasiticides, medicated feed additives, animal health diagnostics and other pharmaceuticals. LIVESTOCK HEALTH BRANDS We support those who raise and care for farm animals with a range of products and services that offer tangible solutions to the many health and productivity challenges they face every day. COMPANION ANIMAL HEALTH BRANDS Our products help improve the quality and extend the lives of cats, dogs and horses. We strive to make it easier for pet owners to maintain the health and wellness of their companions. 12

13

BRINGING VALUE TO SOCIETY OUR SIX AREAS OF SOCIAL RESPONSIBILITY We create value for our business and for society by improving the health of animals; enhancing the sustainability of animal agriculture; and enriching the lives of our customers, colleagues and communities around the world. We strive to use our global leadership, resources, expertise and product portfolio to make a difference in six areas of responsibility. ADVANCE ANIMAL HEALTH PROMOTE THE VETERINARY PROFESSION ENSURE A SAFE AND SUSTAINABLE FOOD SUPPLY We understand that the single most important commitment we make is to advance animal health. By doing so, we help protect and enhance public health as well. We invest in research and development programs within Zoetis and in collaboration with public and private partners to bring novel and enhanced animal health products and technologies to market. Our product portfolio supports our customers in their work to predict, prevent and treat illness in animals and address unmet medical needs. Veterinary professionals play a vital role in society, serving as stewards of animal and public health. We are proud of our six-decade commitment to promote the veterinary profession and help assure a vibrant future led by a new generation of talented leaders. For practicing professionals, we provide technical support and continuing education. We partner with veterinary professional associations and institutions to provide scholarships, career development programs and research fellowships for veterinary students. In developing countries, we participate in collaborations with veterinary colleges and associations to elevate standards of veterinary education, modernize treatment and standards of care, and grant wider access to care. We are working to develop a next generation of animal health solutions that will help farmers and veterinarians produce a safe, affordable and sustainable supply of animal protein despite finite natural resources and other constraints. We seek to hasten the development of digital technologies and diagnostics that help predict disease; genetic tests that can identify traits of resilience to it; vaccines to help prevent disease; and innovative medicines to treat it. We support our customers in the responsible use of antibiotics and believe that veterinary professionals should have oversight on decisions to use them. In poor rural communities of developing markets, we support agricultural development programs that bring education in animal husbandry, as well as increased access to veterinary care to farmers, helping them increase productivity and move from subsistence to sustainability. 14

SUPPORT THE COMMUNITIES WHERE WE OPERATE RUN OUR BUSINESS ETHICALLY AND RESPONSIBLY PROVIDE A WORKPLACE WHERE COLLEAGUES FEEL VALUED We recognize that our ability to contribute to society goes beyond the medicines, vaccines and diagnostic tools we develop. Our people strive to use our resources and expertise to make a difference in the communities where we operate. We participate in organizations dedicated to preparing talented young people for careers in animal agriculture. We support organizations worldwide that share our commitment to pet adoption, and we provide medicines, vaccines and diagnostics to shelters that deliver healthcare for animals awaiting new homes. Zoetis is there when our communities need us most in response to natural disasters. We work with our local teams to respond with financial support and vital veterinary medicines to help protect animal health and welfare. Always Do the Right Thing is one of our Core Beliefs. We view operating our business with integrity as the responsibility of every Zoetis employee. We work to implement sustainable practices directly into the development, manufacture and appropriate use of our products. Zoetis manufacturing sites worldwide strive to reduce waste and water intake and improve energy efficiency. For as long as it remains necessary to use animals in the discovery, development and evaluation of new medicines and therapies for animals, we remain committed to maintaining high standards of animal care and welfare consistent with or exceeding those required by local, national and international laws and regulations. We have created a distinct culture at Zoetis grounded in our Core Beliefs a culture in which integrity, accountability, collaboration and customer focus are the hallmarks of success. With our singular focus on animal health, Zoetis colleagues join in a common purpose, sharing knowledge and resources for the success of our customers those who raise and care for animals. We invest in our people and offer exciting opportunities for colleagues to grow their knowledge and skills and take on more complex challenges. We are committed to fostering a workplace where diversity is valued and discrimination is not tolerated. 15

A GREAT PLACE TO WORK At Zoetis, we know our people drive our success. Our colleagues are proud of our positive company culture and the meaningful role we play in caring for animals. When it comes to our culture, our Core Beliefs are the foundation of the commitments we make to our colleagues, customers and stakeholders every day. They have helped us create an awardwinning workplace and become a leading partner of choice in animal health. Every colleague at Zoetis is encouraged to grow personally and professionally by pursuing their unique career development journey. Supported by managers and the organization, colleagues are empowered to take on challenges and experiences that help them reach their career goals and aspirations. WHAT SETS ZOETIS APART We have a highly collaborative culture at Zoetis, and we work across the business as One Zoetis to achieve results that matter. We believe these results come best in an open, diverse and inclusive environment. As a global business, we operate in 45 countries with colleagues who respect and appreciate each other s differences and cultures. Every Zoetis colleague is encouraged and expected to have a sense of ownership in Zoetis. Our colleagues know their decisions and actions make a direct impact on our business and our customers. At Zoetis, we strive to always do the right thing for our colleagues, for our business and for our society. Whether it is helping pets live longer, happier and healthier lives, or helping ensure safe and affordable nutrition for people through healthier livestock, Zoetis colleagues bring value to society and our business by improving the health of animals. We have a singular focus on animal health that fosters a run it like you own it mindset among our teams. COME JOIN US WWW.ZOETIS.COM/CAREERS 16

ZOETIS GLOBAL HEADQUARTERS 10 Sylvan Way Parsippany, New Jersey 07054 973-822-7000 www.zoetis.com All trademarks are the property of Zoetis Inc. or its subsidiaries, affiliates or licensors. 2019 Zoetis Inc. All rights reserved. WWW.ZOETIS.COM